英国国民保健署会为新一代痴呆症药物买单吗？

英国国民保健署 (NHS) 拒绝为阿尔茨海默病药物乐卡奈单抗 (lecanemab) 提供资金，引发了争议。尽管该药物备受关注，但它并非“神药”。

## Original Title: Will the NHS ever pay for the new era of dementia drugs?

## Article Content:
The choice to not fund Alzheimer’s drug lecanemab caused upset, but it is not a “wonder drug”.

Original article: https://www.bbc.com/news/articles/cvg5nder03go